Margaret Reinhart, NP
Nurse Practitioner · Savannah, GANPI 1730339219
Payments from drug & device makers
Across 192 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$702
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$673
- Biodelivery Sciences International, Inc.$245
- AbbVie$242
- Boston Scientific$191
- Forte Bio-pharma LLC$169
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,605100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 38 | $702 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 43 | $673 |
| Biodelivery Sciences International, Inc. | 15 | $245 |
| AbbVie | 13 | $242 |
| Boston Scientific | 10 | $191 |
| Forte Bio-pharma LLC | 6 | $169 |
| Idorsia Pharmaceuticals US Inc | 7 | $157 |
| Amgen | 8 | $156 |
| Teva Pharmaceuticals USA, Inc. | 3 | $147 |
| Scilex Pharmaceuticals Inc. | 6 | $117 |
| Redhill Biopharma Inc. | 6 | $113 |
| Lundbeck LLC | 4 | $97 |
| Pfizer | 4 | $72 |
| IBSA Pharma Inc. | 3 | $52 |
| Almatica Pharma LLC | 3 | $51 |
| Averitas Pharma Inc. | 2 | $48 |
| Vertex | 2 | $43 |
| GRT US Holding, Inc. | 2 | $34 |
| Tonix Medicines, Inc. | 1 | $32 |
| Eisai Inc. | 2 | $31 |
| Virtus Pharmaceuticals LLC | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $26 |
| Medtronic | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$116
How this compares
$3,605 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 57 | $17,104 |
| MovantikNaloxegol Oxalate | 18 | $7,253 |
| LinzessLinaclotide | 11 | $5,849 |
| Diclofenac Sodium | 57 | $4,379 |
| Gabapentin | 377 | $4,274 |
| Lidocaine | 55 | $4,134 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $3,183 |
| Pregabalin | 179 | $2,879 |
| Chlorzoxazone | 18 | $1,894 |
| Buprenorphine Hcl | 48 | $1,823 |
| Tizanidine Hcl | 202 | $1,413 |
| Naloxone Hcl | 18 | $1,217 |
| Baclofen | 126 | $1,154 |
| Tramadol Hcl | 155 | $1,115 |
| Lubiprostone | 11 | $787 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Buprenorphine Hcl | $19 | $22,109124 claims |
| Redhill Biopharma Inc.Movantik | $113 | $7,25318 claims |
| AbbVieLinzess | $242 | $5,84911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Savannah
- Crystal LogsdonSavannah$566K
- Jessica AdkinsSavannah$226K
- Luis PoloSavannah$70K
- Wallette WidenerSavannah$20K
- Angie MoyeSavannah$14K
- Amy CarterSavannah$11K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.